Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth.

abdominal aortic aneurysm disease-modifying anti-rheumatic drugs interleukin tumour necrosis factor-α

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
26 Sep 2022
Historique:
received: 26 07 2022
revised: 28 08 2022
accepted: 20 09 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

Inflammation is strongly implicated in the pathogenesis of abdominal aortic aneurysms (AAA). This review examined the potential role of biologic disease-modifying anti-rheumatic drugs (bDMARDs) as repurposed drugs for treating AAA. Published evidence from clinical and preclinical studies was examined. Findings from animal models suggested that a deficiency or inhibition of tumour necrosis factor-α (TNF-α) (standard mean difference (SMD): -8.37, 95% confidence interval (CI): -9.92, -6.82), interleukin (IL)-6 (SMD: -1.44, 95% CI: -2.85, -0.04) and IL-17 (SMD: -3.36, 95% CI: -4.21, -2.50) led to a significantly smaller AAA diameter compared to controls. Human AAA tissue samples had significantly increased TNF-α (SMD: 1.68, 95% CI: 0.87, 2.49), IL-1β (SMD: 1.93, 95% CI: 1.08, 2.79), IL-6 (SMD: 2.56, 95% CI: 1.79, 3.33) and IL-17 (SMD: 6.28, 95% CI: 3.57, 8.99) levels compared to non-AAA controls. In human serum, TNF-α (SMD: 1.11, 95% CI: 0.25, 1.97) and IL-6 (SMD: 1.42, 95% CI: 0.91, 1.92) levels were significantly elevated compared to non-AAA controls. These findings implicate TNF-α, IL-17 and IL-6 in AAA pathogenesis. Randomised controlled trials testing the value of bDMARDs in limiting AAA growth may be warranted.

Identifiants

pubmed: 36289670
pii: biomedicines10102409
doi: 10.3390/biomedicines10102409
pmc: PMC9598733
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : National Health and Medical Research Council
ID : 117601

Références

Transfusion. 2012 Aug;52(8):1761-9
pubmed: 22304534
Sci Rep. 2019 Jul 18;9(1):10447
pubmed: 31320700
Vasc Endovascular Surg. 2009 Jun-Jul;43(3):258-61
pubmed: 19131369
Cardiovasc Pathol. 2010 Jan-Feb;19(1):48-54
pubmed: 19150246
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Surg Res. 2001 Dec;101(2):152-6
pubmed: 11735270
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2605-13
pubmed: 16973970
Arch Med Sci. 2014 Dec 22;10(6):1175-85
pubmed: 25624856
J Vasc Surg. 2006 Mar;43(3):474-80
pubmed: 16520158
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):843-853
pubmed: 29472233
Clin Sci (Lond). 2008 Jun;114(11):687-97
pubmed: 18078385
Immunity. 2013 Dec 12;39(6):1003-18
pubmed: 24332029
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):
pubmed: 28620097
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):294-304
pubmed: 23288154
Clin Chem Lab Med. 2000 Nov;38(11):1161-4
pubmed: 11156350
Semin Arthritis Rheum. 2014 Feb;43(4):489-97
pubmed: 24012043
BMC Musculoskelet Disord. 2015 Oct 20;16:309
pubmed: 26481039
Cytokine. 2009 May;46(2):211-5
pubmed: 19251434
Ann Rheum Dis. 2017 Jun;76(6):1101-1136
pubmed: 28298374
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2429-38
pubmed: 25234817
Circulation. 2006 Mar 21;113(11):e463-654
pubmed: 16549646
Medicine (Baltimore). 2017 Feb;96(7):e6055
pubmed: 28207513
Eur J Vasc Endovasc Surg. 2009 Mar;37(3):305-10
pubmed: 19111481
Clin Exp Immunol. 1994 Nov;98(2):337-43
pubmed: 7955542
J Vasc Surg. 1992 Nov;16(5):784-9
pubmed: 1433667
Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):457-463
pubmed: 29217508
Int J Cardiol. 2020 Aug 1;312:100-106
pubmed: 32334849
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
Clin Sci (Lond). 2012 Feb;122(4):143-59
pubmed: 22029668
Expert Opin Ther Pat. 2008 Jul;18(7):723-738
pubmed: 19578469
Circ Res. 2019 Feb 15;124(4):631-646
pubmed: 30763216
Abdom Radiol (NY). 2018 May;43(5):1032-1043
pubmed: 29313113
Ann Rheum Dis. 2015 Jun;74(6):1087-93
pubmed: 24685910
N Engl J Med. 2002 May 9;346(19):1445-52
pubmed: 12000814
Circulation. 1994 Nov;90(5 Pt 2):II224-7
pubmed: 7955258
J Immunol. 2009 Aug 15;183(4):2741-6
pubmed: 19620291
Eur J Vasc Endovasc Surg. 1999 Apr;17(4):294-300
pubmed: 10204050
Nat Rev Cardiol. 2019 Apr;16(4):225-242
pubmed: 30443031
J Vasc Surg. 1998 Sep;28(3):522-6
pubmed: 9737463
Immunol Rev. 2018 Jan;281(1):8-27
pubmed: 29247995
Scand J Immunol. 2010 Aug;72(2):150-7
pubmed: 20618774
Nat Rev Drug Discov. 2018 Jun;17(6):395-412
pubmed: 29725131
Arthritis Rheum. 2008 Jun 15;59(6):762-84
pubmed: 18512708
Curr Drug Targets. 2018;19(11):1241-1246
pubmed: 29284388
Br J Dermatol. 2020 Mar;182(3):605-617
pubmed: 31218661
J Intern Med. 2020 Jul;288(1):6-22
pubmed: 31278799
Rheumatology (Oxford). 2014 Jan;53(1):186-94
pubmed: 24140761
MAbs. 2011 Nov-Dec;3(6):535-45
pubmed: 22123062
World J Surg. 2003 Apr;27(4):476-80
pubmed: 12658496
Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93
pubmed: 30528142
Dermatol Ther (Heidelb). 2020 Jun;10(3):431-447
pubmed: 32200512
Ann Rheum Dis. 2013 Apr;72(4):517-24
pubmed: 22562972
Ann Vasc Surg. 2014 Nov;28(8):1913-22
pubmed: 25011090
Regul Pept. 2012 Nov 10;179(1-3):50-4
pubmed: 22982141
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2843-7
pubmed: 9409264
Arterioscler Thromb Vasc Biol. 1999 Jul;19(7):1695-9
pubmed: 10397687
Med Sci Sports Exerc. 2018 Apr;50(4):649-658
pubmed: 29210916
Immunity. 2017 Nov 21;47(5):959-973.e9
pubmed: 29150241
Ann Med. 2015 May;47(3):245-52
pubmed: 25856542
Eur J Vasc Endovasc Surg. 2000 Nov;20(5):462-5
pubmed: 11112466
J Vasc Surg. 2007 Mar;45(3):574-80
pubmed: 17321344
Eur Heart J. 2013 Dec;34(48):3707-16
pubmed: 23111417
Curr Rheumatol Rep. 2014 Aug;16(8):431
pubmed: 24925587
BMC Genomics. 2007 Jul 16;8:237
pubmed: 17634102
Atherosclerosis. 2011 Oct;218(2):470-8
pubmed: 21722904
Circulation. 2012 Sep 11;126(11 Suppl 1):S38-45
pubmed: 22965992
Semin Arthritis Rheum. 2011 Apr;40(5):398-406
pubmed: 20843542
Cytokines Cell Mol Ther. 2002;7(3):91-7
pubmed: 12850808
J Vasc Surg. 2007 Feb;45(2):350-6
pubmed: 17264016
Int J Mol Med. 2007 Sep;20(3):391-5
pubmed: 17671746
Surgery. 2018 Aug;164(2):354-358
pubmed: 29716755
Clin Sci (Lond). 2004 Mar;106(3):301-6
pubmed: 14580234
J Immunol Res. 2019 Aug 6;2019:9782594
pubmed: 31467936
Ann Med. 2015;47(6):441-6
pubmed: 26339779
Int J Cardiol. 2018 Nov 1;270:221-227
pubmed: 29884291
Glob Heart. 2014 Mar;9(1):159-70
pubmed: 25432125
Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):212-223
pubmed: 30580570
Atherosclerosis. 2016 Aug;251:139-146
pubmed: 27318834
Ann Rheum Dis. 2020 Jun;79(6):685-699
pubmed: 31969328
PLoS One. 2017 Oct 5;12(10):e0185923
pubmed: 28982132
Arthritis Res Ther. 2019 May 2;21(1):111
pubmed: 31046809
Ann Thorac Surg. 2015 Nov;100(5):1620-6
pubmed: 26165482
RMD Open. 2019 Aug 1;5(2):e000887
pubmed: 31452928
Clin Biochem. 2010 Mar;43(4-5):407-10
pubmed: 19932694
Circ Genom Precis Med. 2019 Feb;12(2):e002413
pubmed: 30657332
Nat Rev Rheumatol. 2018 Nov;14(11):622
pubmed: 30305698
Surgery. 1999 Oct;126(4):624-7; discussion 627-8
pubmed: 10520907
J Vasc Surg. 2010 Jul;52(1):145-51
pubmed: 20620767
Thromb Res. 2012 Sep;130(3):511-3
pubmed: 22633212
J Vasc Surg. 2018 Apr;67(4):1248-1262
pubmed: 28434701

Auteurs

Shivshankar Thanigaimani (S)

The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD), College of Medicine and Dentistry, James Cook University, Townsville, QLD 4811, Australia.
The Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, QLD 4811, Australia.

Muhammad Ibrahim (M)

The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD), College of Medicine and Dentistry, James Cook University, Townsville, QLD 4811, Australia.

Jonathan Golledge (J)

The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD), College of Medicine and Dentistry, James Cook University, Townsville, QLD 4811, Australia.
The Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, QLD 4811, Australia.
The Department of Vascular and Endovascular Surgery, Townsville University Hospital, Townsville, QLD 4811, Australia.

Classifications MeSH